Pureos Bioventures
Venture Capital
Active
Pfaffikon, Switzerland
26
48M
19
5
0.27
1
- Stages of investment
- Areas of investment
Summary
The usual cause for the fund is to invest in rounds with 5-6 partakers. Despite the Pureos Bioventures, startups are often financed by Ysios Capital, Kurma Partners, BB Biotech Ventures. The meaningful sponsors for the fund in investment in the same round are Bpifrance, Ysios Capital, Quark Venture.
The common things for fund are deals in the range of 10 - 50 millions dollars. The top activity for fund was in 2019. The fund is generally included in 2-6 deals every year. Speaking about the real fund results, this VC is 47 percentage points more often commits exit comparing to other organizations.
The fund has no exact preference in some founders of portfolio startups. Among the most popular fund investment industries, there are Pharmaceutical, Biotechnology. Besides, a startup requires to be at the age of 11-15 years to receive the investment from the fund. Among the most popular portfolio startups of the fund, we may highlight AM Pharma, NovaGo Therapeutics.
Investor highlights
- Industry focus
- Stage focus
Discover reliable insights
Find relevant VC investors, identify key contacts and secure funding opportunities.
Investments analytics
Last fund
- Fund size
- USD 205000000
- Fund raised date
- 2021-04-22
Analytics
- Total investments
- 26
- Lead investments
- 5
- Exits
- 1
- Follow on index
- 0.27
- Investments by industry
- Biotechnology (20)
- Therapeutics (13)
- Health Care (10)
- Medical (8)
- Life Science (6) Show 9 more
- Investments by region
-
- Netherlands (4)
- Switzerland (8)
- United States (2)
- France (6)
- Singapore (1) Show 3 more
- Peak activity year
- 2020
Discover reliable insights
Leverage validated data, identify key contacts and secure funding opportunities for your business.Quantitative data
- Avg. startup age at the time of investment
- 9
- Group Appearance index
- 0.96
Need more data?
Get access to full data about investors, including their team, contact information, and historic data.
Latest deals
| Company name | Deal date | Industry | Deal stage | Deal size | Location |
|---|---|---|---|---|---|
| Adcytherix | 11 Jun 2024 | Seed | 35M | Noord-Holland, Amsterdam, The Netherlands | |
| Ariceum Therapeutics | 08 Jun 2022 | Health Care, Medical, Therapeutics | Early Stage Venture | 29M | Berlin, Berlin, Germany |
| StartBull | 01 Jun 2013 | Internet, Financial Services, Social Network, Social Media | Seed | 118K | Valle del Cauca, Buenaventura, Colombia |
Similar funds
By same location
By same geo focus
By doing lead investments
At Unicorn Nest, we combine cutting-edge technology with human expertise to build one of the most reliable venture capital databases in the market. Our process begins with automated AI-enhanced data collection, leveraging the full potential of Large Language Models (LLMs).
Later, our team of analysts takes it further with manual verification, using proprietary tools for data cleaning and validation to ensure accuracy and reliability. We cross-check and enhance our findings through press and media monitoring, integrating information from trusted news outlets and venture capital aggregators. Finally, we stay ahead of the curve by monitoring social networks like LinkedIn and X.com.